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Clinical Applications of Impulse 
Oscillometry
Constantine Saadeh and Nicole Davey-Ranasinghe
Abstract
Impulse oscillometry is a noninvasive procedure that can be performed within 
few minutes. The purpose of the procedure is to measure the resistance of the 
small and large airways, as well as the reactants of the airways. It is gradually 
gaining popularity in evaluating lung function, particularly in patients with 
asthma and COPD. In contrast to spirometry, the test performs measurement 
during tidal breathing. In other words, forced exhalation is not required. Other 
advantages include, but are not limited to, evaluating COPD patients’ reversibil-
ity which is rarely noted on spirometry. IOS also is tool for chronic management 
of patients with asthma and COPD while on treatment. It can evaluate children 
with asthma even as young as 2 years old. Spirometry requires the child to coop-
erate and usually is of meaningful use beginning at the age of 5 years old. Other 
potential applications include early evaluation of transplant rejection, cystic 
fibrosis, and vocal cord disorder. In this chapter, we will explore the procedure 
itself, the settings, advantages and disadvantages, and comparative data with 
spirometry.
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1. Introduction
The expert panel 3 of the National Asthma Education and Prevention Program 
defines asthma as “a common chronic disorder of the airways that is complex and 
characterized by variable and recurring symptoms, airflow obstruction, bronchial 
hyperresponsiveness, and an underlying inflammation. The interaction of these 
features of asthma determines the clinical manifestations and severity of asthma 
and the response to treatment.” This definition allows for incorporation of the 
clinical, physiological, and pathological findings of asthma. Traditional spirom-
etry, while the gold standard, can be unreliable in pediatric patients and is depen-
dent on patient effort. Impulse oscillometry is a clinical tool that is independent 
of patient effort and allows for diagnosis and management of pediatric and adult 
patients with asthma. IOS can enhance the clinical evaluation for patients with 
asthma. IOS is a technique that measures airway impedance (resistance and reac-
tance). IOS is a noninvasive technique that is beneficial either as a single modality 
or in combination with traditional spirometry for patients in the diagnosis and 
management of asthma.
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2. Overview
Impulse oscillometry or IOS is a measure of both small and large airway resis-
tance. In addition, resonance capacitance or reactance is also obtained via impulse 
spirometry. It is also referred to as forced oscillation since impulses are sent at 
periodic intervals into the airways. The measurement of airway resistance and 
reactance is performed in a noninvasive, relatively independent, and minimally 
intrusive manner during spontaneous tidal breathing [1].
In contrast to traditional spirometry, impulse oscillometry or IOS tracing is 
independent of age, height, weight, or gender in adolescents or adults 13 years 
or older. In other words, normal values are the same whether the patient is 13 or 
60 years old. The most relevant findings include R5, R15 or higher, and AX. R5 
reflects the small airway resistance. However, R5 is the summation of small and 
large airways. R15 or higher signifies only the larger airways. AX is low-frequency 
integrated impedance reactance at R5 and is referred to as purely reactance.
In this chapter, we will review briefly the IOS procedure. We will then guide the 
reader to the useful applications of this methodology and the diagnosis and follow-
up in patients with asthma in terms of actual diagnosis, follow-up with treatment as 
outpatient, and documentation of response to treatment. Response to treatment can 
be gauged via handheld nebulizer treatment in the acute setting. In addition, treat-
ment with inhaled corticosteroids or inhaled corticosteroid/LABA or long-acting beta 
agonists has also been observed independent of spirometry [2]. We will also review the 
literature regarding the comparison of this modality to traditional spirometry. Finally, 
we will briefly outline future directions in the evaluation of other respiratory disorders.
3. Impulse oscillometry
3.1 Technique
The technique of IOS is effort independent. However, it does require breathing 
through the mouth as noted below. The IOS technique was performed as previously 
described. Briefly, patients are seated comfortably in a no swivel chair (Figure 1).
Nose clips were applied, and a special mouthpiece was used. For IOS measure-
ments, patients may be advised to cradle their cheeks with their hands. Patients 
are allowed to breathe normally while the loudspeaker delivered intermittent 
Figure 1. 
The subject during tidal breathing inhales and exhale in a closed system. Technician is watching the screen for 
the sinusoidal waves to pick up the best reading.
3Clinical Applications of Impulse Oscillometry
DOI: http://dx.doi.org/10.5772/intechopen.85890
multi-frequency impulses over a minimum of a 30-s period. A trained technician 
will be guiding and assisting the patient during the procedure, which involves three 
to five sinusoidal readings, depending on the incidence of cough, swallowing, and 
holding of breath. The recordings with the best coherence at frequencies from 5 
to 30 Hz were chosen. The technician was also trained to capture subclinical leaks 
through the mouthpiece, and leaky recordings were discarded. The pre- and post-
bronchodilator assessments took at least 10 min and used ultrasonic nebulizer. The 
IOS parameters measured were R5, R15, and AX.
Traditionally, spirometry is utilized to evaluate lung function in both children 
and adults. There is no doubt that spirometry is of greater utility at least for most 
practitioners who diagnose and manage asthma. However, the limitations include 
difficulty conducting the measurement in patients who are less than 5 years old. Even 
in patients who are 5 years old and older, the predicted FEV1 may not be as accurate 
as it is in adults. On the other hand, IOS is more feasible in terms of detecting small 
airway dysfunction [27, 28]. Classically, small airway dysfunction is detected via the 
FEF 25/FEF 75. This is highly volume dependent as patients may be unable to per-
form a complete expiratory maneuver from total lung capacity to residual volume.
Even in adults, spirometry itself has its own limitations. FEV1 or the forced expi-
ration volume in the first second is dependent on the ability of the patient to take a 
deep breath and forcefully exhale until the residual volume is reached. The FEV1 is 
then compared to a predicted value which is determined via statistical analysis of 
normal people. Therefore, patients who participate in athletics, for example, may 
have a higher FEV1 than the predicted value. However, these patients may also have 
abnormal IOS even though they have supernormal FEV1. In addition, patients with 
lower predicted value may show improvement in the IOS even though the spirom-
etry may not change. The improvement can be noted acutely via handheld nebulizer 
or chronically through the use of maintenance inhalers such as corticosteroids.
4. Measurements
Impulse oscillometry in contrast to spirometry measures the resistance and the 
airways as well as the reactants. The resistance in the airways is referred to as R5 
which is the resistance in the small airways. R15 or higher is a measurement of the 
resistance in the larger airways. It is important to note that the resistance in the small 
airways or R5 is the summation of the small and large airways, and therefore the dif-
ference between R5 and R15 or higher is the actual small airway measurement. The 
integrated impedance reactants at R5 or above are referred to as AX. AX is consid-
ered the area under the X curve from the beginning of normal inspiration. The reac-
tants are a more sensitive guideline for patient evaluation and asthma. A normal AX 
is 3 cm of water or less in children who are 13 years and older throughout adulthood. 
Children who are 5 years or younger have poor lung compliance. Therefore, a normal 
AX in this age group varies, but usually it is 30 cm of water or less. Therefore, in the 
younger age group since there is variation in the measurement of AX, it is reason-
able to always measure the AX pre-and post-bronchodilation with short-acting beta 
agonist. This will give better determination of the actual pulmonary status of the 
patient. As a result of that, children who are between the ages of 6 and 12 will have 
an AX in between 30 and 3 cm of water. In this group of patients, it is important to 
follow up these patients not only with measurement of reactance or AX at baseline 
but also to check that nebulizer treatment is followed with short-acting beta. These 
patients were on rather than of equal or less of 1000 µg per day at least 2 weeks after 
treatment with inhaled main tenance corticosteroids or combination. The combina-
tion in general will be inhaled corticosteroids with long-acting beta agonist Figure 3.
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The trained technician will be able to choose the recordings with the best 
coherence at frequencies between 5 and 30 Hz. The ideal coherence should be 0.9, 
1, 1, 1 at 5, 10, 15, and 20 Hz, respectively. The technician is also trained to capture 
subclinical leaks through the mouthpiece, and leak recordings should be discarded.
5. Role of IOS in asthma
Published observations by the author and colleagues have shown that patients 
with asthma showed improvement in the IOS values. This has been observed 
through the measurement of the reactance or AX immediately following nebulizer 
treatment as well as definite improvement 3 months or more after the start of 
inhaled corticosteroids or a combination of inhaled corticosteroids with long-acting 
beta agonist. The FEV1 in these patients showed improvement in the minority of 
patients, while the reactance or AX improved in all the patients who were tested. 
There were 39 patients who were adults in this age group. Figure 1 above shows in 
office IOS. Figures 2 and 3 below revels the improvement in IOS immediately fol-
lowing nebulizer treatment and 3 months later in an individual patient [26–28].
The role of small airway dysfunction in adults with asthma has been demon-
strated in at least 31–47% of 196 patients who were diagnosed with asthma and had 
insufficient control of their symptoms. Twenty percent of these patients had poorly 
controlled asthma. Irrespective of their smoking history, both impulse oscillometry 
and nitric oxide measurements in the exhaled breath or FENO were more sensitive 
Figure 2. 
(a) Patient 15 before bronchodilator. (b) Patient after bronchodilator.
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in predicting small airway dysfunction than traditional spirometric measurements. 
The authors concluded that even though nitric oxide measurement was slightly 
more sensitive than IOS, both of these tests were complimentary in determining the 
severity of peripheral airway dysfunction. However, in this study, the risk factors 
for peripheral airway dysfunction were noted to be in patients who have tradi-
tionally positive smoking history, elevated blood eosinophils, and dose with low 
baseline FEV1. Nevertheless, the role of impulse oscillometry in this study should 
be strongly emphasized (Figure 3) [3].
In children with asthma, IOS was noted to be more useful than spirometry and 
identifying both the asthma and predicting loss of control and exacerbations. This 
can help with early intervention when the spirometry is normal, but the IOS is 
showing abnormality. In particular, children are known to have more peripheral 
or small airway dysfunction. Traditionally this has been dependent upon forced 
expiration flow between 25 and 75%. Recent studies have shown that IOS is a 
better predictor particularly in measurement of the small airways or R5 as well as 
the reactance or AX in the initial evaluation and response to treatment. IOS had 
improved diagnostic capability in identifying patients with uncontrolled asthma 
during select baseline values. In the longitudinal analysis of 54 children between the 
ages of 7 and 17 years old with mild to moderate asthma, both R5 and AX showed 
inadequate control of asthma 8–12 weeks after the initial visit than spirometric 
measurements. This included FEF 25–75%. Scholz and colleagues evaluated the 
value of IOS compared with spirometry and methacholine challenge as predictors 
of asthma exacerbation in children who are 4–7 years old during 1-year observation. 
R5 was more predictive of an exacerbation even at the time when the patient was 
not having any symptoms. The FEV1 or FEV1/FVC and methacholine challenge via 
spirometry were also normal in these children. In preschool children, normal IOS 
findings in children between the ages of 2 and 7 years old in patients with asthma 
are unlikely to have decreased lung function in adolescence based on their initial 
IOS measurements [4, 5].
Small airways of the lung are defined as the bronchial passages that are less than 
2 mm in diameter. They are located beyond the seventh or eighth generation of 
the tracheobronchial tree. These airways account for more than 90% of the cross-
sectional area of the lung and terminate with the alveolar sacs [6].
The small airways have no cartilage to support the structure and are therefore 
more easily collapsible upon compression. Small airway disease affects the major-
ity of asthmatics across the spectrum of severity. The production of small particle 
Figure 3. 
Patient 15 follow-up (post) (shadowed area AX). Notice normal resistance (a) and normal AX (b) following 
inhaled corticosteroids for at least two weeks.
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inhaled corticosteroids has enhanced the delivery of inhaled corticosteroids to 
the smaller airways. This certainly has improved lung function in both adults and 
children with asthma. Traditionally, high-resolution CT of the chest has been a 
noninvasive direct radiographic assessment of the luminal caliber and wall thickness 
of the medium and large airways that are more than 2 mm in diameter. However, this 
modality has difficulty in evaluating airways that are less than 2 mm in diameter. 
About 5–10% of patients with asthma are deemed to have severe disease as defined 
by the European Respiratory Society and the American Thoracic Society as asthma 
that requires treatment with high-dose inhaled corticosteroids plus a second control-
ler and/or systemic corticosteroids to prevent it from becoming uncontrolled or that 
remains uncontrolled despite this therapy. Treatment compliance such as appropri-
ate use of inhalers is essential for disease management [7]. Even though there is no 
gold standard technique for the assessment or diagnosis of small airway, impulse 
oscillometry in particular has been shown to be effective in the evaluation of small 
airways either alone or in a combination with exhaled nitric oxide measurement [8].
6. IOS and airway hyperreactivity
The role of IOS in bronchial challenge has also been studied. Bronchial challenge 
test with methacholine or histamine directly or indirectly such as mannitol may be 
used in every day clinical practice to identify the presence of airway hyperactivity. 
Airway hyperactivity is the hallmark of persistent asthma. It is particularly useful 
when the diagnosis of asthma is in doubt such as patients who are experiencing 
unexplained cough with normal spirometry. Theoretically, performing IOS with 
normal tidal breathing is much easier for patients to perform with repeated mea-
surements during challenge. Bronchial irritation such as coughing may pose some 
limitation while performing the test with spirometry. Eighteen adult patients with 
mild to moderate persistent asthma had methacholine and histamine challenges 
measuring both spirometry and IOS. A decrease in the FEV1 by 20% was almost 
equivalent to a 37% drop in R5 for methacholine and 35% decrease for R5 with 
histamine. The authors concluded that 40% decrease in R5 may be justifiable to 
approximately extrapolate to the drop in the FEV1 by 20% for both methacholine 
and histamine challenge [9, 10]. Similar values on R5 or AX were noted in another 
study. Improvement by 40% or more on the AX value may carry the same signifi-
cance as a drop in the FEV1 by 20% without the risk of irritation through forced 
exhalation. Studies in children are very limited in this regard. One study has noted 
that in children between the ages of 3 and 8 years old, a change in the R5/R20 after 
methacholine challenge was significantly higher in those children with more severe 
asthma as shown by increased exercise-induced bronchospasm and short-acting 
beta 2 agonist use [11].
In another study, 48 young children with asthma undergoing methacholine chal-
lenge noted that a drop of 45% in R5 had the equivalents of a drop in the FEV1 by 
20%. In addition, significant increase in resistance was seen well before a change in 
the FEV1 at lower methacholine dosages suggesting that IOS is more sensitive than 
spirometry [12].
Hyperresponsiveness was also studied in patients with mild to moderate adult 
asthma. Patients were recruited between the ages of 18 and 65 years old. FEV1 was 
noted to be greater than 80% of what is predicted in these patients. Diurnal FEV1 
variation was less than 30%. These patients were on equal or less of 1000 mcg/day 
of beclomethasone dipropionate or equivalent dose. These patients were recruited 
prospectively. Bronchial challenge was performed with inhaled methacholine and 
histamine. Twenty-one participants were randomized. Eighteen of whom, ten 
7Clinical Applications of Impulse Oscillometry
DOI: http://dx.doi.org/10.5772/intechopen.85890
women and eight men, completed the protocol. All of these patients were used in 
this analysis, and the mean age was 36 years old. The PC 20 over the FEV1 dropped 
by 20% following the challenge was noted at equivalents of 43.5% drop in R5 and 
the methacholine challenge, while it was 45% on the histamine challenge. The 
magnitude of change seen was greater for all IOS indices including R5 and R5–R20 
area under the curve as well as what is referred to as resident frequency or X5. X5 
correlated well with the AX. The significance of this study is that these patients 
were identified as having mild to moderate adult asthma. These patients were well 
controlled with inhaled corticosteroids. Therefore, they had normal FEV1 at base-
line. This study correlated with what has been reported in the literature regarding 
the application of IOS in SSA and hyperactivity in patients with asthma [13].
In terms of bronchial hyperresponsiveness, cough is an important consideration. 
Cough is a complex reflex that typically acts as a valuable protective airway clear-
ance mechanism. It arises from irritation of the intrapulmonary and extrapulmo-
nary airways. When the cough reflex is activated, there is an initial inspiratory phase 
followed by the glottic closure. There is prompt increase in intrathoracic pressure. 
This is followed by forced expiration and the opening of the glottis. As a result, gas 
is expired at a high flow rate along with the characteristic audible sound recognized 
as cough. Patients with asthma or chronic cough and suspected cough-variant 
asthma participated in a prospective study. The purpose of the study was to compare 
the bronchodilating effect of deep inspiration in patients with chronic asthma, 
cough-variant asthma, and chronic cough using high dose of methacholine. These 
were patients who are between the ages of 18 and 65. Twenty-eight patients out of 
56 that were screened were included in the study. Fifteen of these patients were 
taking inhaled corticosteroids, and nine were taking long-acting beta agonist. The 
total resistance did not differ significantly on any of these 3 groups. However, small 
airway resistance or R5 worsened in patients with cough-variant asthma and chronic 
asthma but did not with chronic cough. Similar findings were noted with spirom-
etry. The purpose of the study was to show that deep inspiration can reverse the 
obstructive effect due to airway closure but not the obstruction due to large airway 
narrowing. However, as a secondary finding, impulse oscillometry reproduces the 
same results as spirometry with methacholine challenge with more comfort during 
the study. This correlated with the other findings as noted above [14].
7. IOS and pro-inflammatory mediators
Asthma is considered a chronic respiratory disease characterized by airway 
inflammation. Airway inflammation can lead to airway remodeling and hyper-
responsiveness. Airway remodeling refers to the structural changes in the airway 
including but not limited to the airway smooth muscle, airway epithelia, blood 
vessels, as well as the extracellular matrix. This can manifest itself as an increase in 
the airway smooth muscle mass, epithelial injury, epithelial cell hyperplasia, goblet 
cell hyperplasia, thickening of the basement membrane, and angiogenesis. The 
mechanism of airway remodeling is still unclear. It is noted that multiple cytokines, 
chemokines, and transcription factors as well as growth factors are released from 
inflammatory cells. Structural cells are also involved in the airway remodeling. For 
example, TGF-beta and vascular endothelial growth factor or VEGF are released by 
the structural cells.
Follistatin-like protein 1 or FSTL1 is also known as transforming growth factor-
beta 1-stimulated clone 36. It is a secreted glycoprotein of 308 amino acids. The 
function of FSTL1 is not completely understood. It has been shown to play a key 
role in tumor propagation and bone metastasis, chronic pain hypersensitivity, 
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inflammation and insulin resistance, and obesity and regulation of erythropoiesis 
as well as physical development. Several studies have shown that FSTL1 may play an 
important role in the respiratory system. It is important in lung development, carti-
lage formation, and alveolar maturation. No count of FSTL1 and mice is embryonic 
clear lethal, and these mice display multiple developmental abnormalities of the 
respiratory and skeletal systems. In a recent study, 32 asthmatics and 25 controls 
were enrolled for routine blood testing. Spirometry and impulse oscillometry were 
performed. Fiberoptic bronchoscopy was also performed in the 32 asthmatics. 
The study was aimed at measuring FSTL1 levels. However, it was noted that IOS 
measurements in these patients were more sensitive than that of spirometry. FSTL1 
levels were higher in asthmatics and improved with treatment. IOS showed more 
improvement than FEV1 in the same patients where the FSTL1 was decreased. 
Indirectly, therefore IOS may be considered a more accurate measurement of the 
inflammatory process and airway remodeling in the lung than spirometry [15].
8. IOS and beta-2 receptor polymorphism
Gly16Arg beta-2 receptor genotype is a variant allele in the polymorphism 
of Beta 2 adrenergic receptor family. In other words, in asthmatic children, the 
presence of this LDL is associated with sub-sensitivity response following exposure 
to regular long-acting beta-2 agonist in asthmatic patients receiving concurrent 
inhaled corticosteroids. In a study involving 112 patients treated with inhaled 
corticosteroids with a mean age of 43 years old, there was no difference in response 
to treatment with inhaled corticosteroids or combination of inhaled corticosteroids 
with long-acting beta agonist in terms of IOS response. In other words, allelic varia-
tion of the beta-2 adrenergic receptor did not influence the IOS outcomes [16].
9. IOS and observations in pre-asthma
In a recent study, 21 school children participated in a 6-minute walk with a 
measurement of spirometry and IOS before the 6-minute walk, post 6-minute walk, 
followed by 30-minute of rest, and an additional 6-minute walk, IOS, and spirom-
etry. One hundred twenty-three children participated, but only 21 school children 
were able to perform the spirometric maneuvers according to preestablished 
inclusion criteria. Of the 21 children, 9 were able to perform the 6-minute walk 
with no changes in the IOS. Significant increase in R5 as well as R20 was noted in 
the rest of the children who participated. Spirometry did not change, but there was 
a decrease in the FEF 25–75%. The importance of this study is that it suggests that 
greater attention should be given to submaximal test particularly in children who 
are predisposed to airway alterations [17].
On the other hand, body mass index status can play an important role in the base-
line reactance curve in children who are between the ages of 8 and 16 years. At the age 
of 16 years, there was increased blood neutrophil count in overweight obese girls but 
not in boys. However, both genders showed increased reactance or AX even though 
these patients were not complaining of symptoms to suggest asthma. The nitric oxide 
washout was normal in this population. The R5 was higher in this age group. IOS 
therefore can be a predictor of possible asthma in adolescence with high BMI [18].
Passive smoking may result in alteration of pulmonary function in infants 
born preterm. A study of 139 children between the ages of 3 and 7 years old who 
were born late preterm were categorized whether they had presence or absence of 
exposure to passive smoking. Patients who are exposed to passive smoking had a 
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higher R5 and are 5/20 as well as a higher AX than patients who were not exposed to 
passive smoking. Passive smoking therefore can be a factor in early asthma develop-
ment particularly in this patient population [19].
In conclusion, IOS or impulse oscillometry has been shown to reflect improve-
ment in lung function following short-acting beta agonist treatment, as well as with 
long-term use of inhaled corticosteroids or combination of inhaled corticosteroids 
with long-acting beta agonist. The improvement was noted in multiple studies to 
be independent of the change or status of routine spirometry. It may also provide a 
better assessment of small airways through its R5 and AX measurements.
In addition, IOS can be more useful and effort independent in measurement 
of airway hyperresponsiveness in adults and children. It appears to be along with 
the measurement of nitric oxide exhalation to be reflective of the status of airway 
inflammation. The observed improvement and IOS are independent of the allele 
change or polymorphism of the beta-2 adrenergic receptor. It can play a role in the 
detection of early asthma particularly in children who are obese or exposed to pas-
sive smoking. This can be detected either by baseline IOS measurement or following 
6-minute walk.
Monoclonal antibodies have been used in the treatment of severe asthma. These 
are patients who are either unresponsive to high-dose inhaled corticosteroids or 
are unable to be weaned off by oral corticosteroids. These patients have at least two 
exacerbations within 6 months. In following these patients, there is very limited data 
about the role of IOS at baseline and during follow-up. We have published data in an 
abstract form on 12 patients who were on omalizumab that showed improvement in 
the IOS but not spirometry with follow-up. These patients also improved in terms 
of tapering high-dose inhaled corticosteroids or oral steroids and had a decrease in 
their exacerbations even though there was no change in their FEV1. Future studies in 
this regard in patients with high IgE and eosinophilic asthma are warranted.
10. Role of IOS and COPD
In patients with COPD, it is well known that spirometry can be used to define 
the GOLD criteria. In other words, the FEV1 and the FVC are important parameters 
in defining the stage of the GOLD criteria. However, in general patients with COPD 
or chronic obstructive pulmonary disease had very little change upon follow-up in 
terms of improvement in the lung function based on the spirometry. Therefore, the 
most reliable current guidelines include quality of life, smoking cessation, 6-minute 
walk, oxygenation, and perhaps improvement in the FEV1. There have been several 
reports that showed that the impulse oscillometry can improve even though the spi-
rometry does not change both in terms of short-term treatment with short-acting 
beta agonists and long-acting beta agonist/long-acting muscarinic antagonists with 
or without inhaled corticosteroids.
A study of 215 participants IOS was studied in the setting of chronic obstruc-
tive pulmonary disease or COPD of which 18, 83, 78, and 36 patients were classi-
fied under the GOLD criteria as grade 1, 2, 3, and 4, respectively. IOS parameters 
showed worsening of R5 and reactance or AX depending upon the severity of their 
COPD. There was a negative correlation with spirometry at baseline. This study 
recorded IOS at baseline, and it showed good correlation with traditional pulmo-
nary parameters. The conclusion was that IOS can be used as an alternative method-
ology for evaluation of patients with COPD [1].
The diagnosis of COPD can be difficult at times particularly in the early stages. 
Thirty-five patients who had moderate to severe COPD showed improvement 
both in the AX and the resistance in the small airways following treatment with 
Asthma - Biological Evidences
10
long-acting beta agonist/long-acting muscarinic antagonist combination. The 
improvement was more prominent than the improvement noted in the FEV1. In 
fact, FEV1 and FVC statistical significance for the small sample size was not pres-
ent. IOS improvement was noted in follow-up visit of these patients [20].
Another study evaluated IOS in a pediatric patients, in the use of combination 
of fluticasone and salmeterol combined with tiotropium, there was significant 
improvement in R5 and AX in patients who received the triple combination as 
compared to patients who only received tiotropium by itself. In this study, spiro-
metric findings were also noted to improve with the triple combination. However, 
IOS findings appear to be more significant. The conclusion by the authors is that 
IOS may provide a physiological point of view that is different from spirometry 
and seemed to be applicable as an additional assessment tool targeting COPD 
patients [21].
These patients were noted at baseline to improve in terms of IOS even though the 
spirometry did not change. There was also improvement in the impulse oscillom-
etry or AX with follow-up. Statistical significance was noted with improvement in 
AX, R5, and R15 despite the lack of improvement in FEV1. In conclusion, there was 
improvement in the impulse oscillometry at baseline as well as maintenance follow-
up therapy in patients with mild to moderate COPD.
Peripheral airway dysfunction was also noted in COPD patients who experi-
ence sleep disturbance. Fifty patients were evaluated in the morning after sleep. 
Questionnaires were given about the quality of sleep. IOS measurements were noted 
to be abnormal particularly increased AX and R5. The study demonstrated that 
sleep disturbances due to COPD symptoms are associated with airway constriction 
which is reflective of peripheral airway dysfunction [22].
On the whole, the studies suggest that impulse oscillometry may offer a new clue 
in the diagnosis and follow-up of patients with COPD. The limitation of the studies 
is that a combination of asthma and COPD cannot be entirely excluded. It has been 
suggested that nitric oxide measurement is helpful in the differentiation of combi-
nation of asthma/COPD and COPD. In patients with COPD by itself, nitric oxide 
measurement in the exhaled breath is usually very low and is in general less than 5. 
However, further studies in this regard are needed to reaffirm these findings.
11. IOS and other respiratory conditions
Cystic fibrosis is a multisystem disease with respiratory system involvement 
responsible for 90% of morbidity and mortality. Conventional spirometry is consid-
ered the main method to evaluate airway disease in patients with cystic fibrosis. FEV1 
has been recognized as an objective parameter to evaluate the course of the disease and 
response to treatment. Forty-nine cystic fibrosis patients between the ages 3 and 18 
were compared to 45 healthy controls. IOS was performed in both groups. Spirometry 
was also performed in patients who are more than 6 years old, while patients who 
were less than 6 years old only had IOS. In both groups, it was noted that the resistance 
increased and so did the AX during exacerbation and decreased after treatment. This 
was independent of the bronchodilator effects. IOS therefore may be useful to evaluate 
pulmonary function and detect acute exacerbation in cystic fibrosis patients [23].
Hypersensitivity pneumonitis is a complex clinical syndrome that results from 
abnormal immune lung function to diverse inhaled antigens. It can be related to 
protein antigens denied from birds as well as air conditioning and can progress to 
pulmonary fibrosis. Small airway involvement is associated with interstitial mono-
nuclear infiltrate with non-necrotizing poorly formed granulomas and varying 
degree of fibrosis. Therefore, detection of small airway dysfunction is essential in 
11
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establishing the severity of the disease process. In a study of 20 consecutive patients 
with established diagnosis of hypersensitivity pneumonitis, there was ventilation 
perfusion mismatch. IOS was obtained, and it did show elevated AX at baseline and 
improved with treatment particularly with azathioprine and prednisone. It is noted 
that lung volume also improved but not gas exchange [24].
A case report in 2005 demonstrated a lung transplant patient who had deteriora-
tion in the IOS even though the spirometry did not change. The AX was worse and 
so was the resistance in the small and large airways. This was reflective of early 
transplant rejection. The usefulness of IOS in monitoring lung transplant patient 
was evaluated by Dr. Ochman and published in 2018. The study involved 25 consec-
utive patients with successful lung transplantation, and 88% of these patients were 
noted to have increased AX indicating peripheral airway obstruction. There was an 
increase in the small airway resistance or R5 as well. The median age was 46 years 
old. This was a baseline study but suggested that IOS measurements may also be 
important in evaluating possible early rejection in patients with lung transplant [25].
Finally, it is well noted that vocal cord disorder in patients with chronic cough, 
uncontrolled COPD, or severe asthma can be a contributing factor to the worsening 
of the symptoms. We have noted that a ratio of AX on inspiration/AX expiration 
of greater than 2 is consistent with vocal cord disorder. Improvement in vocal cord 
disorder such as treatment of asymptomatic reflux, increased postnasal drip, and 
vocal cord dysfunction can lead to secondary improvement in asthma and other 
related conditions.
12. Conclusion
The clinical utility of IOS in asthma is well established. IOS is a noninvasive 
tool that is independent of patient effort and reproducible in pediatric and adult 
patients. IOS serves as a technique that can be used with spirometry or indepen-
dently to diagnose and manage asthma. In addition, the utility of IOS is expanding 
and has shown to be useful in COPD and other inflammatory lung diseases.
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